Benefit from our extensive experience from developing a proprietary pipeline
Glycotope is one of the few biotech companies able to develop therapeutic proteins, particularly antibodies, all the way down from gene to a clinical-grade drug product.
Glycotope has a proven track record in successful cell line and process development for the production of fully human, glyco-optimized recombinant products. Our philosophy is to use state-of-the-art technologies to develop efficacious biotherapeutic products.
Customers benefit from our extensive experience in the development of fully human, glyco-optimized monoclonal antibodies and proteins for a wide range of indications as well as having access to our proprietary technologies, GlycoExpress™ (GEX™) and GlycoBody™ (GET™).